These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. The International Society for Heart and Lung Transplantation. 18th annual meeting and scientific sessions. Chicago, Illinois, USA. April 15-18, 1998. Abstracts. J Heart Lung Transplant; 1998 Jan; 17(1):43-136. PubMed ID: 9583906 [No Abstract] [Full Text] [Related]
24. BIO 2005 Annual International Convention. Emerging regions. Zarkowska T IDrugs; 2005 Aug; 8(8):616-8. PubMed ID: 16044364 [No Abstract] [Full Text] [Related]
25. Abstracts of the 2005 AAHPERD (American Alliance for Health, Physical Education, Recreation and Dance) National Convention. Chicago, Illinois, USA, April 12-16, 2005. Res Q Exerc Sport; 2005 Mar; 76(1 Suppl):A1-134. PubMed ID: 15810153 [No Abstract] [Full Text] [Related]
26. Analysis of Well Characterized Biotechnology Pharmaceuticals. Conference proceedings. San Francisco, California, USA. 6-8 January 1997. J Pharm Biomed Anal; 1997 Dec; 16(4):ix, 553-640. PubMed ID: 9565451 [No Abstract] [Full Text] [Related]
27. The use of stem cells in biomedical research. Biotechnology Industry Organization (BIO) position statement. Biotechnology Industry Organization J Biolaw Bus; 1999; 3(1):40-4. PubMed ID: 11933970 [TBL] [Abstract][Full Text] [Related]
28. Development of Specifications for Biotechnology Pharmaceutical Products. San Francisco, California, USA. May 2-3, 1996. Symposium proceedings. Dev Biol Stand; 1997; 91():1-117. PubMed ID: 9463055 [No Abstract] [Full Text] [Related]
29. Placing bets on biotech. Weintraub K Cancer Discov; 2011 Nov; 1(6):462. PubMed ID: 22586641 [No Abstract] [Full Text] [Related]
30. BIO 2005 Annual International Convention. Focus on early-stage Japanese biotech companies. Zarkowska T IDrugs; 2005 Aug; 8(8):619-21. PubMed ID: 16044365 [No Abstract] [Full Text] [Related]
31. Bio-Vision 2016: the second national framework plan for biotechnology promotion in Korea. Hyeon BH; Kim HY; Lee CM; Moon SH; Kim ES; Lee SY Biotechnol J; 2008 May; 3(5):591-600. PubMed ID: 18446865 [No Abstract] [Full Text] [Related]
32. Approval times for supplemental indications for recombinant proteins. Gosse ME; Nelson TF Nat Biotechnol; 1997 Feb; 15(2):130-4. PubMed ID: 9035135 [No Abstract] [Full Text] [Related]
33. AMERICAN Association of Immunologists, Thirty-seventh Annual Meeting, Chicago, Illinois, April 6-10, 1953. Fed Proc; 1953 Mar; 12(1-1):435-66. PubMed ID: 13033933 [No Abstract] [Full Text] [Related]
34. AMERICAN Association of Immunologists, Thirty-seventh Annual Meeting, Chicago, Illinois, April 6-10, 1953. Fed Proc; 1953 Mar; 12(1-2):563-9. PubMed ID: 13033940 [No Abstract] [Full Text] [Related]
36. Therapeutic insight 2004. 3-4 May 2004, Jersey City, NJ, USA. Nicoletti A IDrugs; 2004 Jul; 7(7):644-7. PubMed ID: 15243865 [No Abstract] [Full Text] [Related]
37. Abstracts of the 11th International Kidney Cancer Symposium Annual Meeting. Chicago, Illinois, USA. October 5-6, 2012. BJU Int; 2012 Oct; 110 Suppl 2():1-23. PubMed ID: 22985275 [No Abstract] [Full Text] [Related]
38. AMERICAN Society for Experimental Pathology, Thirty-eighth Annual Meeting, Chicago, Illinois, April 6-10, 1953. Fed Proc; 1953 Mar; 12(1-1):383-407. PubMed ID: 13033931 [No Abstract] [Full Text] [Related]
39. AMERICAN Society of Biological Chemist, Forty-fourth Annual Meeting, Chicago, Illinois, April 6-10, 1953. Fed Proc; 1953 Mar; 12(1-1):165-296. PubMed ID: 13033929 [No Abstract] [Full Text] [Related]
40. AMERICAN Society of Biological Chemist, Forty-fourth Annual Meeting, Chicago, Illinois, April 6-10, 1953. Fed Proc; 1953 Mar; 12(1-2):507-30. PubMed ID: 13033936 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]